Literature DB >> 20339964

Cardiac imaging and safety evaluation of BMS747158, a novel PET myocardial perfusion imaging agent, in chronic myocardial compromised rabbits.

Ming Yu1, Jody Bozek, Mary Guaraldi, Mikhail Kagan, Michael Azure, Simon P Robinson.   

Abstract

BACKGROUND: BMS747158 labeled with (18)F is being developed for PET myocardial perfusion imaging. Imaging studies showed clear detection of necrotic tissue in acute myocardial infarcted (MI) animals and a good safety profile in normal animals. This study evaluated BMS747158 imaging and cardiovascular safety in a rabbit model of chronic MI with cardiac compromise. METHODS AND
RESULTS: Chronic MI rabbits were developed by the left coronary artery ligation followed by 4 weeks recovery. Cardiac PET imaging with BMS747158 (~1.5 mCi, iv) in control rabbits showed clear and uniform myocardial uptake. However, imaging in chronic MI rabbits demonstrated obvious defect area in the left ventricular wall. Before BMS747158 injection, baseline electrocardiogram (ECG) waveforms in lead II configuration were normal with positive QRS complexes in control rabbits. In contrast, MI rabbits exhibited negative QRS complexes with enlarged Q waves and inverted T waves. Baseline values of mean intra-arterial pressure (AP, 61 +/- 6 vs 89 +/- 11 mmHg), systolic AP (79 +/- 11 vs 114 +/- 11 mmHg) and diastolic AP (53 +/- 4 vs 76 +/- 10 mmHg) were lower in MI than in control rabbits. Heart rate (162 +/- 36 vs 159 +/- 8 beat/minute) and QTc interval (corrected by Fridericia method, 288 +/- 17 vs 319 +/- 17 ms) were comparable. BMS747158 administration induced no changes from baseline in any of the measured cardiovascular parameters and ECG waveforms in either control or MI rabbits.
CONCLUSIONS: Cardiac imaging with BMS747158 allows clear detection of chronic MI without producing any cardiovascular alterations in cardiac compromised rabbits.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20339964     DOI: 10.1007/s12350-010-9221-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  19 in total

Review 1.  Infarct scar: a dynamic tissue.

Authors:  Y Sun; K T Weber
Journal:  Cardiovasc Res       Date:  2000-05       Impact factor: 10.787

Review 2.  Myocardial perfusion imaging agents: SPECT and PET.

Authors:  George A Beller; Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2004 Jan-Feb       Impact factor: 5.952

3.  Cardiac sympathetic nerve function in congestive heart failure.

Authors:  G Eisenhofer; P Friberg; B Rundqvist; A A Quyyumi; G Lambert; D M Kaye; I J Kopin; D S Goldstein; M D Esler
Journal:  Circulation       Date:  1996-05-01       Impact factor: 29.690

4.  Effects of reperfusion after coronary artery occlusion on post-infarction scar tissue.

Authors:  C M Connelly; W M Vogel; A W Wiegner; E L Osmers; O H Bing; R A Kloner; D M Dunn-Lanchantin; C Franzblau; C S Apstein
Journal:  Circ Res       Date:  1985-10       Impact factor: 17.367

5.  Use of the rabbit with a failing heart to test for torsadogenicity.

Authors:  Robert L Hamlin; Anusak Kijtawornrat
Journal:  Pharmacol Ther       Date:  2008-04-20       Impact factor: 12.310

6.  Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model.

Authors:  S G Nekolla; S Reder; A Saraste; T Higuchi; G Dzewas; A Preissel; M Huisman; T Poethko; T Schuster; M Yu; S Robinson; D Casebier; J Henke; H J Wester; M Schwaiger
Journal:  Circulation       Date:  2009-04-20       Impact factor: 29.690

7.  Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha.

Authors:  Takao Makino; Yuichi Hattori; Naoyuki Matsuda; Hisao Onozuka; Ichiro Sakuma; Akira Kitabatake
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

8.  The evolution of electrocardiographic changes in ST-segment elevation myocardial infarction.

Authors:  Jose Victor Nable; William Brady
Journal:  Am J Emerg Med       Date:  2009-07       Impact factor: 2.469

9.  Extraneuronal enzymatic degradation of myocardial interstitial norepinephrine in the ischemic region.

Authors:  Takafumi Fujii; Toji Yamazaki; Tsuyoshi Akiyama; Shunji Sano; Hidezo Mori
Journal:  Cardiovasc Res       Date:  2004-10-01       Impact factor: 10.787

10.  Evaluation of a novel (18)F-labeled positron-emission tomography perfusion tracer for the assessment of myocardial infarct size in rats.

Authors:  Hossam M Sherif; Antti Saraste; Eliane Weidl; Axel W Weber; Takahiro Higuchi; Sybille Reder; Thorsten Poethko; Gjermund Henriksen; David Casebier; Simon Robinson; Hans-Jürgen Wester; Stephan G Nekolla; Markus Schwaiger
Journal:  Circ Cardiovasc Imaging       Date:  2009-01-26       Impact factor: 7.792

View more
  9 in total

1.  Novel F-18-labeled PET myocardial perfusion tracers: bench to bedside.

Authors:  Stephan G Nekolla; Antti Saraste
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

2.  Cardiac PET/CT for the evaluation of known or suspected coronary artery disease.

Authors:  Marcelo F Di Carli; Venkatesh L Murthy
Journal:  Radiographics       Date:  2011 Sep-Oct       Impact factor: 5.333

3.  A new simplified volume-loaded heterotopic rabbit heart transplant model with improved techniques and a standard operating procedure.

Authors:  Wei Lu; Jun Zheng; Xu-Dong Pan; Bing Li; Jin-Wei Zhang; Long-Fei Wang; Li-Zhong Sun
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

4.  (18)F-labeled rhodamines as potential myocardial perfusion agents: comparison of pharmacokinetic properties of several rhodamines.

Authors:  Mark D Bartholomä; Shaohui Zhang; Vamsidhar Akurathi; Christina A Pacak; Patricia Dunning; Frederic H Fahey; Douglas B Cowan; S Ted Treves; Alan B Packard
Journal:  Nucl Med Biol       Date:  2015-06-18       Impact factor: 2.408

5.  Effect of the prosthetic group on the pharmacologic properties of 18F-labeled rhodamine B, a potential myocardial perfusion agent for positron emission tomography (PET).

Authors:  Mark D Bartholomä; Vijay Gottumukkala; Shaohui Zhang; Amanda Baker; Patricia Dunning; Frederic H Fahey; S Ted Treves; Alan B Packard
Journal:  J Med Chem       Date:  2012-12-14       Impact factor: 7.446

6.  LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment.

Authors:  Ming Yu; Jody Bozek; Melanie Lamoy; Mikhail Kagan; Pedro Benites; David Onthank; Simon P Robinson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-04       Impact factor: 9.236

7.  EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging.

Authors:  Roberto Sciagrà; Mark Lubberink; Fabien Hyafil; Antti Saraste; Riemer H J A Slart; Denis Agostini; Carmela Nappi; Panagiotis Georgoulias; Jan Bucerius; Christoph Rischpler; Hein J Verberne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-02       Impact factor: 9.236

8.  The allometric model in chronic myocardial infarction.

Authors:  Maria P Bonomini; Pedro D Arini; Germán E Gonzalez; Bruno Buchholz; Max E Valentinuzzi
Journal:  Theor Biol Med Model       Date:  2012-05-11       Impact factor: 2.432

Review 9.  Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers.

Authors:  Rudolf A Werner; Xinyu Chen; Steven P Rowe; Constantin Lapa; Mehrbod S Javadi; Takahiro Higuchi
Journal:  Int J Cardiovasc Imaging       Date:  2018-10-17       Impact factor: 2.357

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.